| 产品名 | |||
| Vorapaxar | Protease-activated Receptor | 外周动脉疾病,心肌梗死 | 2014/5/8 |
| Ceritinib (LDK378) | ALK | 肺癌 | 2014/4/29 |
| Apremilast (CC-10004) | PDE | 关节炎,牛皮癣 | 2014/3/21 |
| Dapagliflozin | SGLT | 糖尿病 | 2014/1/8 |
| Sofosbuvir (PSI-7977, GS-7977) | HCV Protease | HCV感染 | 2013/12/6 |
| Simeprevir | HCV Protease | HCV感染 | 2013/11/12 |
| Ibrutinib (PCI-32765) | BTK | 淋巴瘤,白血病 | 2013/11/1 |
| Macitentan (ACT064992) | Endothelin Receptor | 肺动脉高压 | 2013/10/18 |
| Riociguat | Others | 肺动脉高压 | 2013/10/8 |
| Dolutegravir (DTG, GSK1349572) | Integrase | 艾滋病毒感染 | 2013/8/12 |
| Afatinib (BIBW2992) | EGFR | 肺癌 | 2013/7/20 |
| Trametinib (GSK1120212) | MEK | 黑色素瘤 | 2013/5/29 |
| Dabrafenib (GSK2118436) | Raf | 黑色素瘤 | 2013/5/29 |
| Canagliflozin | SGLT | 糖尿病 | 2013/3/29 |
| Pomalidomide (CC-4047) | TNF-alpha | 骨髓瘤 | 2013/2/8 |
| Alogliptin (SYR-322) | DPP-4 | 糖尿病 | 2013/1/25 |
| Ponatinib (AP24534) | Bcr-Abl | 白血病 | 2012/12/14 |
| Cabozantinib (XL184, BMS-907351) | VEGFR | 甲状腺癌,肾细胞癌 | 2012/11/29 |
| Cabozantinib S-Malate | VEGFR | 甲状腺癌 | 2012/11/29 |
| Tofacitinib (CP-690550) Citrate | JAK | 类风湿性关节炎 | 2012/11/6 |
| Regorafenib (BAY 73-4506) | VEGFR | 结肠直肠癌,胃肠道间质瘤 | 2012/9/27 |
| Bosutinib (SKI-606) | Src | 白血病 | 2012/9/4 |
| Enzalutamide (MDV3100) | Androgen Receptor | 前列腺癌 | 2012/8/31 |
